Bruker vs Qiagen
Bruker (BRKR), health care, and Qiagen (QGEN), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Qiagen is worth $10.3B on the stock market and Bruker $9.4B: Qiagen is valued at 10% more. Bruker's operating margin in its latest fiscal year was 1.98% and Qiagen's 22.3%. Over the past year Bruker's share price has moved +42.1% and Qiagen's +12.3%.
Key facts
- Bruker market value
- $9.4B
- Qiagen market value
- $10.3B
- Qiagen P/E
- 26.9
- Bruker revenue
- $3.4BFY to 2025-12-31
- Qiagen revenue
- $2.1BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Bruker | Qiagen |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $9.4Blower | $10.3Bhigher |
| Revenue | $3.4Bhigher | $2.1Blower |
| Earnings | -$8.6Mlower | $424.9Mhigher |
| Employees | 11,085higher | 5,400lower |
| Total assets | $6.2Blower | $6.3Bhigher |
| Valuation | ||
| P/E | — | 26.9 |
| P/S | 2.7lower | 4.9higher |
| P/B | 4.1 | — |
| Dividend yield | 0.08% | — |
| Profitability | ||
| Operating margin | 1.98%lower | 22.3%higher |
| Balance sheet | ||
| Net assets | $2.5Blower | $3.8Bhigher |
| Total liabilities | $3.7Bhigher | $2.5Blower |
| Total debt | $1.9Bhigher | $1.7Blower |
| Cash on hand | $298.8Mlower | $839Mhigher |
| Price change | ||
| Today | +1.22%higher | -0.12%lower |
| 1 year | +42.1%higher | +12.3%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Bruker only (4)
Qiagen only (0)
None of the tracked investors.
Percentages are each holding's share of that investor's reported portfolio. Who owns BRKR
More on Bruker
Further comparisons
Bruker against its closest peers
Qiagen against its closest peers
Learn
Questions and answers
Which is bigger, Bruker or Qiagen?
By market value, Qiagen is the larger: $10.3B against $9.4B for Bruker. By revenue in its latest fiscal year, Bruker is the larger: $3.4B against $2.1B for Qiagen.
Which has the higher operating margin?
Qiagen: 22.3%, against 1.98% for Bruker. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has more debt?
Bruker: $1.9B, against $1.7B for Qiagen. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Bruker and Qiagen?
None of the tracked superinvestors holds both in their latest 13F filing. 4 hold Bruker and 0 hold Qiagen.
Cite this page
Funkfolio, “Bruker vs Qiagen”, data as of 18 November 2026. https://funkfolio.com/compare/brkr-vs-qgen
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.